Jaber, Samir http://orcid.org/0000-0002-7257-8069
,
Rollé, Amélie
Godet, Thomas
Terzi, Nicolas
Riu, Béatrice
Asfar, Pierre
Bourenne, Jeremy
Ramin, Séverin
Lemiale, Virginie
Quenot, Jean-Pierre
Guitton, Christophe
Prudhomme, Eloi
Quemeneur, Cyril
Blondonnet, Raiko
Biais, Mathieu
Muller, Laurent
Ouattara, Alexandre
Ferrandiere, Martine
Saint-Léger, Piehr
Rimmelé, Thomas
Pottecher, Julien
Chanques, Gerald
Belafia, Fouad
Chauveton, Claire
Huguet, Helena
Asehnoune, Karim
Futier, Emmanuel
Azoulay, Elie
Molinari, Nicolas
De Jong, Audrey
Funding for this research was provided by:
Centre Hospitalier Régional Universitaire de Montpellier
Article History
Received: 30 March 2021
Accepted: 20 April 2021
First Online: 25 May 2021
Declarations
:
: SJ reports receiving consulting fees from Drager, Medtronic, Baxter, Fresenius-Xenios, and Fisher & Paykel. TR is a paid consultant of bioMerieux and Baxter. He has received grant support from bioMerieux, Baxter and Fresenius Medical Care and fees for lectures during industry symposia for bioMerieux, Baxter, Fresenius Medical Care, Bbraun and Nikkiso. VL reported being a member of a research group that has received grants from Alexion, Baxter, MSD, Gilead, Sanofi, Celgène. ADJ reports receiving consulting fees from Medtronic. No conflict of interests is reported for other authors.
: The trial was approved for all centers by a central Ethics Committee (Comité de Protection des Personnes Nord-Ouest, France, 2019-A01180-57) according to French law. An informed consent was required. The STYLETO trial was conducted in accordance with the declaration of Helsinki and was registered atExternalRef removedwith trial identification number NCT04079387 before the first inclusion in the trial.
Free to read: This content has been made available to all.